Sawahata T, Neal R A
Mol Pharmacol. 1983 Mar;23(2):453-60.
Hepatic microsomal biotransformation of phenol to hydroquinone and catechol has been investigated with special reference to the covalent binding to microsomal protein of reactive metabolites formed during microsomal metabolism of phenol. Incubation of [14C]phenol with microsomes from phenobarbital-treated rat liver in the presence of an NADPH-generating system resulted in the formation of hydroquinone and catechol in the ratio of 20:1. No significant formation of 1,2,4-benzenetriol was observed. The biotransformation of phenol to both hydroquinone and catechol required NADPH and molecular oxygen. NADH was much less effective than NADPH as an electron donor and exhibited no significant synergistic effect when used together with NADPH. The biotransformation was inhibited by typical cytochrome P-450 inhibitors such as carbon monoxide, SKF 525-A, and metyrapone. These results indicated the involvement of cytochrome P-450 in the microsomal hydroxylation of phenol at both the ortho- and para-positions. Covalent binding of radioactivity to microsomal protein was observed when [14C]phenol was incubated with rat liver microsomes in the presence of an NADPH-generating system. The covalent binding was also found to require NADPH and molecular oxygen. Inclusion of cytochrome P-450 inhibitors in the incubation mixture resulted in a decrease in the covalent binding. These results indicated that at least one step in the metabolic activation of phenol to the metabolites responsible for covalent binding to microsomal protein was mediated by cytochrome P-450. Inclusion of N-acetylcysteine in the incubation mixture resulted in the complete inhibition of the covalent binding of radioactivity derived from [14C]phenol to microsomal protein, and there was a concomitant formation of N-acetylcysteine adducts of hydroquinone and catechol. These results indicated that hydroquinone and catechol were both precursors to reactive metabolites responsible for the covalent binding.
已对苯酚在肝微粒体中生物转化为对苯二酚和邻苯二酚进行了研究,特别关注了苯酚微粒体代谢过程中形成的活性代谢物与微粒体蛋白的共价结合。在存在NADPH生成系统的情况下,将[14C]苯酚与苯巴比妥处理的大鼠肝脏微粒体一起孵育,导致对苯二酚和邻苯二酚以20:1的比例形成。未观察到1,2,4-苯三酚的显著形成。苯酚向对苯二酚和邻苯二酚的生物转化需要NADPH和分子氧。NADH作为电子供体的效果远不如NADPH,并且与NADPH一起使用时未表现出显著的协同作用。生物转化受到典型的细胞色素P-450抑制剂如一氧化碳、SKF 525-A和甲吡酮的抑制。这些结果表明细胞色素P-450参与了苯酚在邻位和对位的微粒体羟基化反应。当在存在NADPH生成系统的情况下将[14C]苯酚与大鼠肝脏微粒体一起孵育时,观察到放射性与微粒体蛋白的共价结合。还发现共价结合也需要NADPH和分子氧。在孵育混合物中加入细胞色素P-450抑制剂会导致共价结合减少。这些结果表明,苯酚代谢活化为负责与微粒体蛋白共价结合的代谢物的过程中,至少有一个步骤是由细胞色素P-450介导的。在孵育混合物中加入N-乙酰半胱氨酸会导致源自[14C]苯酚的放射性与微粒体蛋白的共价结合完全受到抑制,同时形成了对苯二酚和邻苯二酚的N-乙酰半胱氨酸加合物。这些结果表明,对苯二酚和邻苯二酚都是负责共价结合的活性代谢物的前体。